의료 관류 기술 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00019844
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 173
Buy Now

의료 관류 기술 시장은 2019년 7억 710만 달러에서 2027년 9억 6260만 달러에 달할 것으로 예상됩니다. 시장은 2020년부터 2027년까지 연평균 4.1% 성장할 것으로 예상됩니다.



의료 관류 기술 시장의 범위에는 기술, 장기 유형, 구성 요소 및 지역이 포함됩니다. 지역에 따라 의료 관류 기술 시장은 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미로 분류됩니다. 이 보고서는 시장 동향, 기술 발전, 시장 역학 및 전 세계 주요 시장 참가자의 경쟁 구도 분석과 같은 다양한 매개 변수를 강조하는 의료 관류 기술 시장에 대한 통찰력과 심층 분석을 제공합니다. 또한 모든 지역에 대한 COVID-19 영향 분석도 포함됩니다.



의료 관류 기술 시장의 수익성 있는 지역




시장 통찰력



세포 기반 연구 활동을 위한 관류 기기



만성 질환의 증가와 생명 공학 응용의 이점은 세포 기반 연구 활동을 광범위하게 강화하고 있습니다. 세포 기반 분석은 세포 신호, 증식, 세포사멸, 세포 유전학, 신경학 및 암과 같은 살아있는 유기체 생물학의 다양한 문제를 이해하는 데 중요한 역할을 합니다.



세포 기반 분석은 다음과 같습니다. 제약, 생명 공학 산업, 연구 기관 및 학술 연구 기관에서 광범위하게 수행됩니다. 제약 및 바이오 제약 산업은 세포 기반 분석법을 사용하여 약물을 효율적으로 상업화합니다.



세포 기반 분석법은 또한 임상 시험 연구 및 기타 프로세스를 위해 계약 연구 기관에서 광범위하게 수행합니다. 암 및 기타 유전 관련 연구와 같은 만성 질환은 세포 기반 연구에 대한 수요를 가속화하고 있습니다. 예를 들어 Charles River는 인간 1차 세포 기반 분석을 위한 서비스를 제공합니다. 회사에서 발표한 기사에 따르면 세포 기반 분석법의 개발은 앞으로도 계속될 것으로 보입니다. 또한 회사는 in vitro와 in vivo 상관 관계가 약물 개발에 중요한 역할을 하기 때문에 세포 기반 분석이 약물 발견에 도움이 된다고 말합니다. 따라서 증가하는 세포 기반 연구 활동은 예측 기간 동안 의료 관류 기술 시장을 주도할 가능성이 높습니다.



기술 기반 통찰력



기술 기반 의료 관류 기술 시장 저체온 기계 관류와 정상 체온 기계 관류로 분류됩니다. 저체온 기계 관류 부문은 2019년에 더 큰 시장 점유율을 차지했습니다. 그러나 정상 온도 기계 관류 부문은 예측 기간 동안 시장에서 4.4%의 더 높은 CAGR을 기록할 것으로 추정됩니다.




글로벌 의료 관류 기술 시장, 기술별 - 2019 및 2027




장기 유형 기반 통찰력



장기 유형에 따라 의료 관류 기술 시장은 심장, 폐, 신장 및 간으로 분류됩니다. 신장 부문은 2019년 시장에서 가장 큰 점유율을 차지했습니다. 그러나 심장 부문은 예측 기간 동안 시장에서 가장 높은 CAGR 4.8%를 기록할 것으로 추정됩니다.




구성 요소 기반 Insights



구성 요소를 기반으로 의료 관류 기술 시장은 관류 펌프, 산소 공급기, 심폐 기계, 모니터링 시스템, 캐뉼라 등으로 분류됩니다. 2019년 산소 공급기 부문은 구성 요소별로 시장에서 가장 큰 점유율을 차지했습니다. 또한 이 부문은 심혈관 수술, 간 이식 및 신장 이식의 증가로 인해 향후 몇 년 동안 가장 빠른 속도로 성장할 것으로 예상됩니다.



전략적 통찰력



파트너십, 인수합병과 같은 비조직적 전략은 기업이 변화하는 고객 요구에 부응하고 전 세계적으로 브랜드 이름을 유지하기 위해 일반적으로 채택됩니다. 의료 관류 기술 시장에서 활동하는 시장 참여자들은 제품 출시 및 확장과 같은 유기적 전략을 채택하여 전 세계적으로 그들의 입지와 제품 포트폴리오를 확장하고 증가하는 수요를 충족합니다.



기술별



< ul>
  • 저체온 기계 관류

  • 정상 체온 기계 관류


  • 장기 유형별





    • 심장


    • 신장


    • 기타


    성분별





    • 관류 펌프

    • 산소 공급기

    • 심폐 기계

    • 모니터링 시스템

    • 캐뉼라

    • 기타

    • 지역별





      • 북미


        • 미국

        • 캐나다

        • 멕시코



      • 유럽


        • 프랑스

        • 독일

        • 이탈리아

        • 영국

        • 스페인
        • 기타 유럽



      • 아시아 태평양(APAC)


        • 중국

        • 인도

        • 남부 한국

        • 일본

        • 호주

        • 기타 APAC



      • 중동 및 아프리카(MEA)< ul>
      • 남아프리카

      • 사우디아라비아

      • UAE

      • 나머지 MEA



    • 남부 중앙 아메리카(SCAM)


      • 브라질

      • 아르헨티나

      • 나머지 SCAM




    회사 프로필





    • Getinge AB

    • Medtronic

    • LivaNova PLC

    • XVIVO 관류

    • Terumo 심혈관 시스템 Corporation

    • OrganOx Limited

    • Waters 의료 시스템

    • TransMedics

    • 장기 복구 시스템

    • XENIOS AG

    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are Medical Perfusion Technology?

    Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time (blood flow) per unit tissue mass. During major surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone.

    What are the driving factors for the Medical Perfusion Technology market across the globe?

    Key factors that are driving the market are rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation and rising cell-based research activities. However, challenging factors such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to show negative impact for the market in few years ahead.

    What is the cost of Medical Perfusion Technology?

    The costs of the medical perfusion technology are much higher, and they may cost US$ 1,0000–5,0000, or more, per software. The cost may also differ from product to product types.

    The List of Companies - Medical Perfusion Technology Market

    1. Getting AB
    2. Medtronic              
    3. LivaNova PLC        
    4. Terumo Corporation          
    5. XVIVO Perfusion                 
    6. OrganOx Limited                 
    7. Waters Medical Systems LLC          
    8. TransMedics         
    9. Organ Recovery Systems                 
    10. Xenios AG - a Fresenius Medical Care company

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports